Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease.
Male
Mice
Animals
Alzheimer Disease
/ genetics
Amyloid beta-Peptides
/ metabolism
Endocannabinoids
/ metabolism
Receptors, Cannabinoid
/ metabolism
Neuroglia
/ metabolism
Microglia
/ metabolism
Hippocampus
/ metabolism
Plaque, Amyloid
/ metabolism
Disease Models, Animal
Cannabinoids
Mice, Transgenic
astroglia
endocannabinoid system
immuno-electron microscopy
microglia
neurodegeneration
Journal
Glia
ISSN: 1098-1136
Titre abrégé: Glia
Pays: United States
ID NLM: 8806785
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
revised:
23
10
2022
received:
02
08
2022
accepted:
18
11
2022
pubmed:
29
11
2022
medline:
17
2
2023
entrez:
28
11
2022
Statut:
ppublish
Résumé
The alteration of the endocannabinoid tone usually associates with changes in the expression and/or function of the cannabinoid CB
Substances chimiques
Amyloid beta-Peptides
0
Endocannabinoids
0
Receptors, Cannabinoid
0
Cannabinoids
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
866-879Informations de copyright
© 2022 The Authors. GLIA published by Wiley Periodicals LLC.
Références
Abate, G., Uberti, D., & Tambaro, S. (2021). Potential and limits of cannabinoids in Alzheimer's disease therapy. Biology (Basel), 10(6), 542. https://doi.org/10.3390/biology10060542
Adermark, L., & Bowers, M. S. (2016). Disentangling the role of astrocytes in alcohol use disorder. Alcoholism: Clinical and Experimental Research, 40(9), 1802-1816. https://doi.org/10.1111/acer.13168
Araque, A., Carmignoto, G., Haydon, P. G., Oliet, S. H., Robitaille, R., & Volterra, A. (2014). Gliotransmitters travel in time and space. Neuron, 81(4), 728-739. https://doi.org/10.1016/j.neuron.2014.02.007
Bard, F., Cannon, C., Barbour, R., Burke, R. L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., … Yednock, T. (2000). Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Medicine, 6(8), 916-919. https://doi.org/10.1038/78682
Bedse, G., Romano, A., Lavecchia, A. M., Cassano, T., & Gaetani, S. (2015). The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease. Journal of Alzheimer's Disease, 43(4), 1115-1136. https://doi.org/10.3233/JAD-141635
Benito, C., Núñez, E., Pazos, M. R., Tolón, R. M., & Romero, J. (2007). The endocannabinoid system and Alzheimer's disease. Molecular Neurobiology, 36(1), 75-81. https://doi.org/10.1007/s12035-007-8006-8
Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003). Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. Journal of Neuroscience, 23(35), 11136-11141. https://doi.org/10.1523/JNEUROSCI.23-35-11136.2003
Beschorner, R., Simon, P., Schauer, N., Mittelbronn, M., Schluesener, H. J., Trautmann, K., Dietz, K., & Meyermann, R. (2007). Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a neuroprotective potential following ischaemia. Histopathology, 50(7), 897-910. https://doi.org/10.1111/j.1365-2559.2007.02703.x
Bisogno, T., & Di Marzo, V. (2010). Cannabinoid receptors and endocannabinoids: Role in neuroinflammatory and neurodegenerative disorders. CNS and Neurological Disorders - Drug Targets, 9(5), 564-573. https://doi.org/10.2174/187152710793361568
Blasko, I., Stampfer-Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., & Grubeck-Loebenstein, B. (2004). How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: The role of microglia and astrocytes. Aging Cell, 3(4), 169-176. https://doi.org/10.1111/j.1474-9728.2004.00101.x
Bonilla-Del Río, I., Puente, N., Mimenza, A., Ramos, A., Serrano, M., Lekunberri, L., Gerrikagoitia, I., Christie, B. R., Nahirney, P. C., & Grandes, P. (2021). Acute Δ9-tetrahydrocannabinol prompts rapid changes in cannabinoid CB1 receptor immunolabeling and subcellular structure in CA1 hippocampus of young adult male mice. Journal of Comparative Neurology, 529(9), 2332-2346. https://doi.org/10.1002/cne.25098
Bonilla-Del Rίo, I., Puente, N., Peñasco, S., Rico, I., Gutiérrez-Rodrίguez, A., Elezgarai, I., Ramos, A., Reguero, L., Gerrikagoitia, I., Christie, B. R., Nahirney, P., & Grandes, P. (2019). Adolescent ethanol intake alters cannabinoid type-1 receptor localization in astrocytes of the adult mouse hippocampus. Addiction Biology, 24(2), 182-192. https://doi.org/10.1111/adb.12585
Bosier, B., Bellocchio, L., Metna-Laurent, M., Soria-Gomez, E., Matias, I., Hebert-Chatelain, E., Cannich, A., Maitre, M., Leste-Lasserre, T., Cardinal, P., Mendizabal-Zubiaga, J., Canduela, M. J., Reguero, L., Hermans, E., Grandes, P., Cota, D., & Marsicano, G. (2013). Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes. Molecular Metabolism, 2(4), 393-404. https://doi.org/10.1016/j.molmet.2013.08.001
Cabral, G. A., & Marciano-Cabral, F. (2005). Cannabinoid receptors in microglia of the central nervous system: Immune functional relevance. Journal of Leukocyte Biology, 78(6), 1192-1197. https://doi.org/10.1189/jlb.0405216
Carlisle, S. J., Marciano-Cabral, F., Staab, A., Ludwick, C., & Cabral, G. A. (2002). Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. International Immunopharmacology, 2(1), 69-82. https://doi.org/10.1016/s1567-5769(01)00147-3
Casarejos, M. J., Perucho, J., Gomez, A., Muñoz, M. P., Fernandez-Estevez, M., Sagredo, O., Fernandez Ruiz, J., Guzman, M., de Yebenes, J. G., & Mena, M. A. (2013). Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. Journal of Alzheimer's Disease, 35(3), 525-539. https://doi.org/10.3233/JAD-130050
Chen, R., Zhang, J., Wu, Y., Wang, D., Feng, G., Tang, Y. P., Chen, C., & Chen, C. (2012). Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. Cell Reports, 2(5), 1329-1339. https://doi.org/10.1016/j.celrep.2012.09.030
Chung, Y. C., Bok, E., Huh, S. H., Park, J. Y., Yoon, S. H., Kim, S. R., Kim, Y. S., Maeng, S., Park, S. H., & Jin, B. K. (2011). Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation. The Journal of Immunology, 187(12), 6508-6517. https://doi.org/10.4049/jimmunol.1102435
de Martín, R., Esteban, S., Benito-Cuesta, I., Terradillos, I., Martínez-Relimpio, A. M., Arnanz, M. A., Ruiz-Pérez, G., Korn, C., Raposo, C., Sarott, R. C., Westphal, M. V., Elezgarai, I., Carreira, E. M., Hillard, C. J., Grether, U., Grandes, P., Grande, M. T., & Romero, J. (2022). Cannabinoid CB2 receptors modulate microglia function and amyloid dynamics in a mouse model of Alzheimer's disease. Frontiers in Pharmacology, 13, 841766. https://doi.org/10.3389/fphar.2022.841766
De Meij, J., Alfanek, Z., Morel, L., Decoeur, F., Leyrolle, Q., Picard, K., Carrier, M., Aubert, A., Séré, A., Lucas, C., Laforest, G., Helbling, J. C., Tremblay, M. E., Cota, D., Moisan, M. P., Marsicano, G., Layé, S., & Nadjar, A. (2021). Microglial cannabinoid type 1 receptor regulates brain inflammation in a sex-specific manner. Cannabis and Cannabinoid Research, 6(6), 488-507. https://doi.org/10.1089/can.2020.0170
Delcambre, G. H., Liu, J., Herrington, J. M., Vallario, K., & Long, M. T. (2016). Immunohistochemistry for the detection of neural and inflammatory cells in equine brain tissue. PeerJ, 4, e1601. https://doi.org/10.7717/peerj.1601
Duffy, S. S., Hayes, J. P., Fiore, N. T., & Moalem-Taylor, G. (2021). The cannabinoid system and microglia in health and disease. Neuropharmacology, 190, 108555. https://doi.org/10.1016/j.neuropharm.2021.108555
Duncan, M., Galic, M. A., Wang, A., Chambers, A. P., McCafferty, D. M., McKay, D. M., Sharkey, K. A., & Pittman, Q. J. (2013). Cannabinoid 1 receptors are critical for the innate immune response to TLR4 stimulation. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 305(3), R224-R231. https://doi.org/10.1152/ajpregu.00104.2013
Dzyubenko, E., Gottschling, C., & Faissner, A. (2016). Neuron-glia interactions in neural plasticity: Contributions of neural extracellular matrix and perineuronal nets. Neural Plasticity, 2016, 5214961. https://doi.org/10.1155/2016/5214961
Egaña-Huguet, J., Bonilla-Del Río, I., Gómez-Urquijo, S. M., Mimenza, A., Saumell-Esnaola, M., Borrega-Roman, L., García Del Caño, G., Sallés, J., Puente, N., Gerrikagoitia, I., Elezgarai, I., & Grandes, P. (2021). The absence of the transient receptor potential vanilloid 1 directly impacts on the expression and localization of the endocannabinoid system in the mouse hippocampus. Frontiers in Neuroscience, 15, 645940. https://doi.org/10.3389/fnana.2021.645940
Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R., & Ullrich, O. (2006). The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron, 49(1), 67-79. https://doi.org/10.1016/j.neuron.2005.11.027
Escartin, C., Guillemaud, O., & Carrillo-de Sauvage, M. A. (2019). Questions and (some) answers on reactive astrocytes. Glia, 67(12), 2221-2247. https://doi.org/10.1002/glia.23687
Esposito, G., De Filippis, D., Cirillo, C., Sarnelli, G., Cuomo, R., & Iuvone, T. (2006). The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. Life Sciences, 78(23), 2707-2715. https://doi.org/10.1016/j.lfs.2005.10.023
Facchinetti, F., Del Giudice, E., Furegato, S., Passarotto, M., & Leon, A. (2003). Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia, 41(2), 161-168. https://doi.org/10.1002/glia.10177
Farina, C., Aloisi, F., & Meinl, E. (2007). Astrocytes are active players in cerebral innate immunity. Trends in Immunology, 28(3), 138-145. https://doi.org/10.1016/j.it.2007.01.005
Franklin, K. B. J., & Paxinos, G. (2008). The mouse brain in stereotaxic coordinates. In compact (3rd ed.). San Diego.
Gomez-Nicola, D., & Perry, V. H. (2015). Microglial dynamics and role in the healthy and diseased brain: A paradigm of functional plasticity. The Neuroscientist, 21(2), 169-184. https://doi.org/10.1177/1073858414530512
Gutiérrez-Rodríguez, A., Bonilla-Del Río, I., Puente, N., Gómez-Urquijo, S. M., Fontaine, C. J., Egaña-Huguet, J., Elezgarai, I., Ruehle, S., Lutz, B., Robin, L. M., Soria-Gómez, E., Bellocchio, L., Padwal, J. D., van der Stelt, M., Mendizabal-Zubiaga, J., Reguero, L., Ramos, A., Gerrikagoitia, I., Marsicano, G., & Grandes, P. (2018). Localization of the cannabinoid type-1 receptor in subcellular astrocyte compartments of mutant mouse hippocampus. Glia, 66(7), 1417-1431. https://doi.org/10.1002/glia.23314
Han, J., Kesner, P., Metna-Laurent, M., Duan, T., Xu, L., Georges, F., Koehl, M., Abrous, D. N., Mendizabal-Zubiaga, J., Grandes, P., Liu, Q., Bai, G., Wang, W., Xiong, L., Ren, W., Marsicano, G., & Zhang, X. (2012). Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell, 148(5), 1039-1050. https://doi.org/10.1016/j.cell.2012.01.037
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018). Microglia in Alzheimer's disease. Journal of Cell Biology, 217(2), 459-472. https://doi.org/10.1083/jcb.201709069
Haspula, D., & Clark, M. A. (2020). Cannabinoid receptors: An update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory diseases. International Journal of Molecular Sciences, 21(20), 7693. https://doi.org/10.3390/ijms21207693
Hu, Q. X., Klatt, G. M., Gudmundsrud, R., Ottestad-Hansen, S., Verbruggen, L., Massie, A., Danbolt, N. C., & Zhou, Y. (2020). Semi-quantitative distribution of excitatory amino acid (glutamate) transporters 1-3 (EAAT1-3) and the cystine-glutamate exchanger (xCT) in the adult murine spinal cord. Neurochemistry International, 140, 104811. https://doi.org/10.1016/j.neuint.2020.104811
Kamphuis, W., Orre, M., Kooijman, L., Dahmen, M., & Hol, E. M. (2012). Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model. Glia, 60(4), 615-629. https://doi.org/10.1002/glia.22295
Kaplan, B. L. (2013). The role of CB1 in immune modulation by cannabinoids. Pharmacology & Therapeutics, 137(3), 365-374. https://doi.org/10.1016/j.pharmthera.2012.12.004
Kettenmann, H., Hanisch, U. K., Noda, M., & Verkhratsky, A. (2011). Physiology of microglia. Physiological Reviews, 91(2), 461-553. https://doi.org/10.1152/physrev.00011.2010
Klegeris, A., Bissonnette, C. J., & McGeer, P. L. (2003). Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. British J Pharmacology, 139(4), 775-786. https://doi.org/10.1038/sj.bjp.0705304
Lehre, K. P., Levy, L. M., Ottersen, O. P., Storm-Mathisen, J., & Danbolt, N. C. (1995). Differential expression of two glial glutamate transporters in the rat brain: Quantitative and immunocytochemical observations. Journal of Neuroscience, 15(3 Pt 1), 1835-1853. https://doi.org/10.1523/JNEUROSCI.15-03-01835.1995
Li, Y., Zhou, Y., & Danbolt, N. C. (2012). The rates of postmortem proteolysis of glutamate transporters differ dramatically between cells and between transporter subtypes. Journal of Histochemistry & Cytochemistry, 60(11), 811-821. https://doi.org/10.1369/0022155412458589
Lines, J., Baraibar, A. M., Fang, C., Martin, E. D., Aguilar, J., Lee, M. K., Araque, A., & Kofuji, P. (2022). Astrocyte-neuronal network interplay is disrupted in Alzheimer's disease mice. Glia, 70(2), 368-378. https://doi.org/10.1002/glia.24112
López, A., Aparicio, N., Pazos, M. R., Grande, M. T., Barreda-Manso, M. A., Benito-Cuesta, I., Vázquez, C., Amores, M., Ruiz-Pérez, G., García-García, E., Beatka, M., Tolón, R. M., Dittel, B. N., Hillard, C. J., & Romero, J. (2018). Cannabinoid CB2 receptors in the mouse brain: Relevance for Alzheimer's disease. Journal of Neuroinflammation, 15(1), 158. https://doi.org/10.1186/s12974-018-1174-9
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., Di Marzo, V., & Lutz, B. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418(6897), 530-534. https://doi.org/10.1038/nature00839
Martín-Moreno, A. M., Reigada, D., Ramírez, B. G., Mechoulam, R., Innamorato, N., Cuadrado, A., & de Ceballos, M. L. (2011). Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to Alzheimer's disease. Molecular Pharmacology, 79(6), 964-973. https://doi.org/10.1124/mol.111.071290
McAlpine, C. S., Park, J., Griciuc, A., Kim, E., Choi, S. H., Iwamoto, Y., Kiss, M. G., Christie, K. A., Vinegoni, C., Poller, W. C., Mindur, J. E., Chan, C. T., He, S., Janssen, H., Wong, L. P., Downey, J., Singh, S., Anzai, A., Kahles, F., … Swirski, F. K. (2021). Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease. Nature, 595(7869), 701-706. https://doi.org/10.1038/s41586-021-03734-6
Mecha, M., Carrillo-Salinas, F. J., Feliú, A., Mestre, L., & Guaza, C. (2016). Microglia activation states and cannabinoid system: Therapeutic implications. Pharmacology & Therapeutics, 166, 40-55. https://doi.org/10.1016/j.pharmthera.2016.06.011
Mecha, M., Feliú, A., Carrillo-Salinas, F. J., Rueda-Zubiaurre, A., Ortega-Gutiérrez, S., de Sola, R. G., & Guaza, C. (2015). Endocannabinoids drive the acquisition of an alternative phenotype in microglia. Brain, Behavior, and Immunity, 49, 233-245. https://doi.org/10.1016/j.bbi.2015.06.002
Metna-Laurent, M., & Marsicano, G. (2015). Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors. Glia, 63(3), 353-364. https://doi.org/10.1002/glia.22773
Molina-Holgado, F., Molina-Holgado, E., Guaza, C., & Rothwell, N. J. (2002). Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. Journal of Neuroscience Research, 67(6), 829-836. https://doi.org/10.1002/jnr.10165
Nanclares, C., Baraibar, A. M., Araque, A., & Kofuji, P. (2021). Dysregulation of astrocyte-neuronal communication in Alzheimer's disease. International Journal of Molecular Sciences, 22(15), 7887. https://doi.org/10.3390/ijms22157887
Navarrete, M., & Araque, A. (2008). Endocannabinoids mediate neuron-astrocyte communication. Neuron, 57(6), 883-893. https://doi.org/10.1016/j.neuron.2008.01.029
Navarrete, M., & Araque, A. (2010). Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron, 68(1), 113-126. https://doi.org/10.1016/j.neuron.2010.08.043
Navarro, G., Borroto-Escuela, D., Angelats, E., Etayo, Í., Reyes-Resina, I., Pulido-Salgado, M., Rodríguez-Pérez, A. I., Canela, E. I., Saura, J., Lanciego, J. L., Labandeira-García, J. L., Saura, C. A., Fuxe, K., & Franco, R. (2018). Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia. Brain, Behavior, and Immunity, 67, 139-151. https://doi.org/10.1016/j.bbi.2017.08.015
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., Berry, R., & Vassar, R. (2006). Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. Journal of Neuroscience, 26(40), 10129-10140. https://doi.org/10.1523/JNEUROSCI.1202-06.2006
Oblak, A. L., Lin, P. B., Kotredes, K. P., Pandey, R. S., Garceau, D., Williams, H. M., Uyar, A., O'Rourke, R., O'Rourke, S., Ingraham, C., Bednarczyk, D., Belanger, M., Cope, Z. A., Little, G. J., Williams, S. G., Ash, C., Bleckert, A., Ragan, T., Logsdon, B. A., … Lamb, B. T. (2021). Comprehensive evaluation of the 5xFAD mouse model for preclinical testing applications: A model-AD study. Frontiers in Aging Neuroscience, 13, 713726. https://doi.org/10.3389/fnagi.2021.713726
Oliveira, J. F., & Araque, A. (2022). Astrocyte regulation of neural circuit activity and network states. Glia, 70(8), 1455-1466. https://doi.org/10.1002/glia.24178
Olmos-Alonso, A., Schetters, S. T., Sri, S., Askew, K., Mancuso, R., Vargas-Caballero, M., Holscher, C., Perry, V. H., & Gomez-Nicola, D. (2016). Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology. Brain, 139(Pt 3), 891-907. https://doi.org/10.1093/brain/awv379
Puente, N., Bonilla-Del Río, I., Achicallende, S., Nahirney, P. C., & Grandes, P. (2019). High-resolution immunoelectron microscopy techniques for revealing distinct subcellular type 1 cannabinoid receptor domains in brain. Bio-Protocol, 9(2), e3145. https://doi.org/10.21769/BioProtoc.3145
Ramírez, B. G., Blázquez, C., Gómez del Pulgar, T., Guzmán, M., & de Ceballos, M. L. (2005). Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation. Journal of Neuroscience, 25(8), 1904-1913. https://doi.org/10.1523/JNEUROSCI.4540-04.2005
Renau-Piqueras, J., Zaragoza, R., De Paz, P., Baguena-Cervellera, R., Megias, L., & Guerri, C. (1989). Effects of prolonged ethanol exposure on the glial fibrillary acidic protein-containing intermediate filaments of astrocytes in primary culture: A quantitative immunofluorescence and immunogold electron microscopic study. Journal of Histochemistry & Cytochemistry, 37(2), 229-240. https://doi.org/10.1177/37.2.2642942
Ribeiro, R., Yu, F., Wen, J., Vana, A., & Zhang, Y. (2013). Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis. Neuroscience, 254, 427-442. https://doi.org/10.1016/j.neuroscience.2013.09.005
Ruiz de Martín Esteban, S., Benito-Cuesta, I., Terradillos, I., Martínez-Relimpio, A. M., Arnanz, M. A., Ruiz-Pérez, G., Korn, C., Raposo, C., Sarott, R. C., Westphal, M. V., Elezgarai, I., Carreira, E. M., Hillard, C. J., Grether, U., Grandes, P., Grande, M. T., & Romero, J. (2022). Cannabinoid CB2 receptors modulate microglia function and amyloid dynamics in a mouse model of Alzheimer's disease. Frontiers in Pharmacology, 13, 841766. https://doi.org/10.3389/fphar.2022.841766
Schmitt, A., Asan, E., Püschel, B., & Kugler, P. (1997). Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: Nonradioactive in situ hybridization and comparative immunocytochemistry. Journal of Neuroscience, 17(1), 1-10. https://doi.org/10.1523/JNEUROSCI.17-01-00001.1997
Scuderi, C., Facchinetti, R., Steardo, L., & Valenza, M. (2020). Neuroinflammation in Alzheimer's disease: Friend or foe? The FASEB Journal, 34(S1), 1. https://doi.org/10.1096/fasebj.2020.34.s1.00381
Sheng, W. S., Hu, S., Min, X., Cabral, G. A., Lokensgard, J. R., & Peterson, P. K. (2005). Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia, 49(2), 211-219. https://doi.org/10.1002/glia.20108
Sinha, D., Bonner, T. I., Bhat, N. R., & Matsuda, L. A. (1998). Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: Immunochemical characterization by fusion protein antibodies. Journal of Neuroimmunology, 82(1), 13-21. https://doi.org/10.1016/S0165-5728(97)00181-1
Smit, T., Deshayes, N. A. C., Borchelt, D. R., Kamphuis, W., Middeldorp, J., & Hol, E. M. (2021). Reactive astrocytes as treatment targets in Alzheimer's disease-systematic review of studies using the APPswePS1dE9 mouse model. Glia, 69(8), 1852-1881. https://doi.org/10.1002/glia.23981
Soto-Mercado, V., Mendivil-Perez, M., Velez-Pardo, C., Lopera, F., & Jimenez-Del-Rio, M. (2020). Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPβ fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications. PLoS One, 15(5), e0221669. https://doi.org/10.1371/journal.pone.0221669
Stefano, G. B., Liu, Y., & Goligorsky, M. S. (1996). Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. Journal of Biological Chemistry, 271(32), 19238-19242. https://doi.org/10.1074/jbc.271.32.19238
Steiner, A. A., Molchanova, A. Y., Dogan, M. D., Patel, S., Pétervári, E., Balaskó, M., Wanner, S. P., Eales, J., Oliveira, D. L., Gavva, N. R., Almeida, M. C., Székely, M., & Romanovsky, A. A. (2011). The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors. Journal of Physiology, 589(Pt 9), 2415-2431. https://doi.org/10.1113/jphysiol.2010.202465
Stella, N. (2009). Endocannabinoid signaling in microglial cells. Neuropharmacology, 56(Suppl. 1), 244-253. https://doi.org/10.1016/j.neuropharm.2008.07.037
Stella, N. (2010). Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia, 58(9), 1017-1030. https://doi.org/10.1002/glia.20983
Szabo, M., & Gulya, K. (2013). Development of the microglial phenotype in culture. Neuroscience, 241, 280-295. https://doi.org/10.1016/j.neuroscience.2013.03.033
Talarico, G., Trebbastoni, A., Bruno, G., & de Lena, C. (2019). Modulation of the cannabinoid system: A new perspective for the treatment of the Alzheimer's disease. Current Neuropharmacology, 17(2), 176-183. https://doi.org/10.2174/1570159X16666180702144644
Thion, M. S., Low, D., Silvin, A., Chen, J., Grisel, P., Schulte-Schrepping, J., Blecher, R., Ulas, T., Squarzoni, P., Hoeffel, G., Coulpier, F., Siopi, E., David, F. S., Scholz, C., Shihui, F., Lum, J., Amoyo, A. A., Larbi, A., Poidinger, M., … Garel, S. (2018). Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell, 172(3), 500-516.e16. https://doi.org/10.1016/j.cell.2017.11.042
Verkhratsky, A., & Nedergaard, M. (2018). Physiology of astroglia. Physiological Reviews, 98(1), 239-389. https://doi.org/10.1152/physrev.00042.2016
Waksman, Y., Olson, J. M., Carlisle, S. J., & Cabral, G. A. (1999). The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. Journal of Pharmacology and Experimental Therapeutics, 288(3), 1357-1366.
Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003). Nonpsychotropic cannabinoid receptors regulate microglial cell migration. Journal of Neuroscience, 23(4), 1398-1405. https://doi.org/10.1523/JNEUROSCI.23-04-01398.2003
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003). Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nature Medicine, 9(4), 453-457. https://doi.org/10.1038/nm838